Nublexa (Regorafenib) 40mg

Nublexa (Regorafenib) 40mg is an oral anticancer medication used in targeted therapy. This kinase inhibitor helps slow cancer progression by blocking signals that promote tumor growth. Suitable for ambient storage, it comes in 28-tablet packs for consistent dosing.

Strength

40mg

Pack Size

28s

Storage

Ambient

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nublexa 40mg is primarily used to treat certain types of cancer, including colorectal cancer and gastrointestinal stromal tumors. It belongs to a class of drugs known as kinase inhibitors, which work by blocking specific enzymes that cancer cells need to grow and spread. Patients may ask, 'what is regorafenib used for' when exploring treatment options for advanced cancer types.

Side Effects

Nublexa 40mg may cause side effects such as fatigue, loss of appetite, or hand-foot skin reactions. Some users report mild nausea or diarrhea, which are common with oral anticancer therapies. Individual responses vary, and effects should be monitored by a healthcare provider.

Precautions & Warnings

Keep Nublexa 40mg in its original packaging at room temperature, away from moisture and direct sunlight. Store securely out of reach of children and pets. Avoid crushing or splitting tablets unless directed by a medical professional. Always follow handling instructions provided with the medication.

Avoid Interactions

Nublexa may interact with strong CYP3A4 inhibitors or inducers, altering its effectiveness. Grapefruit products can increase drug levels, while certain anticonvulsants may reduce its activity. Always disclose all medications and supplements to your healthcare provider before starting regorafenib.

Frequently Asked Questions

Regorafenib is used to treat certain cancers, including colorectal cancer and gastrointestinal stromal tumors.

Store at room temperature in a dry place, away from light and out of reach of children.

It may be taken with or without food, but consistency in timing is recommended.

Common effects include fatigue, skin reactions, nausea, and diarrhea.

Yes, it may interact with CYP3A4 inhibitors, inducers, and grapefruit products.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.